News | November 22, 2013

Millar Appointed Exclusive U.S. Distributor of CD Leycom Inca Pressure-Volume Loop System

cd leycom inca blood pressure monitor cardiac diagnostics ep lab heart failure
November 22, 2013 — Millar Inc. and CD Leycom announced the appointment of Millar as the exclusive U.S. distributor of CD Leycom’s clinical Inca in pressure-volume (PV) loop system and disposable clinical PV loop catheters.
The Inca intracardiac analyzer is the world’s only clinically approved device for monitoring the ventricular pressure volume relationship, cardiac contractile state and intraventricular dyssynchrony in real time using a single pressure volume catheter. 
The Inca delivers greater insight into a patient’s cardiac function, providing clinicians with:
  • Real-time intra-beat and beat-to-beat intraventricular measurement of cardiac function and performance, which can provide guidance for Cardiac Resynchronization Therapy (CRT)
  • Real-time operator independent measurement of intraventricular mechanical dyssynchrony, a prerequisite for CRT and heart failure diagnosis
  • Reliable detection and quantification of heart failure conditions such as systolic/diastolic heart failure with low and normal ejection fraction
  • Accurate acquisition, display, analysis and storage of cardiac function data
“The joint effort by Millar and CD Leycom enables us to demonstrate the potential of the clinical PV technology to improve heart failure diagnosis and to fine-tune cardiac interventional therapies for a more efficient treatment and better patient outcome while reducing health care costs,” said Jan Schreuder, CSO, CD Leycom.
“By partnering to serve our mutual worldwide customers, Millar and CD Leycom can more effectively update clinicians regarding the unique benefits of using PV loop technology clinically and provide the level of collaborative support clinicians want,” said Tim Daugherty, director of sales and marketing, Millar, Inc.
The two companies announced the partnership at the annual American Heart Association Exhibition in Dallas, Texas.
For more information:,

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init